documents: DEA-2022-0001-0591
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DEA-2022-0001-0591 | DEA | DEA-2022-0001 | Schedules of Controlled Substances: Placement of 4-hydroxy-N,N-diisopropyltryptamine (4-OH-DiPT), 5-methoxy-alpha-methyltryptamine (5-MeO-AMT), 5-methoxy-N-methyl-N-isopropyltryptamine (5-MeO-MiPT), 5-methoxy-N,N-diethyltryptamine (5-MeO-DET), and N,N-diisopropyltryptamine (DiPT) in Schedule I; Withdrawal and Notice of Hearing | Proposed Rule | 2022-07-27T04:00:00Z | 2022 | 7 | 2022-07-27T04:00:00Z | 2022-07-27T12:21:18Z | 2022-16102 | 0 | 0 | 09000064851ecfe2 |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref